Kymera Therapeutics CEO Nello Mainolfi's Stock Transactions

On October 29, 2025, Nello Mainolfi, the Chief Executive Officer of Kymera Therapeutics, Inc., engaged in several stock transactions. He acquired 30,000 shares of common stock at $2.08 per share and disposed of a total of 30,000 shares through multiple sales at weighted average prices ranging from $59.35 to $61.82. These transactions were executed under a Rule 10b5-1 trading plan adopted on September 6, 2024. Additionally, Mainolfi exercised a stock option for 30,000 shares at $2.08 per share, which was fully vested and exercisable. Following these transactions, Mainolfi's total holdings in Kymera Therapeutics common stock amounted to 660,482 shares.